Synthetic Biology Market: By Technology (Enabled Products(Pharmaceuticals, Chemicals, Biofuels), Enabling Products(DNA Synthesis, Oligonucleotide Synthesis), By Products (Synthetic DNA, XNA, Chassis Organism)), By Application (Chemicals, Pharmaceuticals, Biopharmaceuticals, Agriculture, Others), and Geography
Synthetic Biology Market size was valued at USD 9.4 billion in 2021 and is expected to reach USD 47.4 billion by 2028, at a CAGR of 26% during the forecast period 2022 to 2028. Synthetic biology is a new interdisciplinary area of the medical field that involves the application of engineering principles in biology. Synthetic biology combines various disciplines within both domains such as genetic engineering, biotechnology, molecular engineering biophysics, computer engineering, electrical engineering and other various branches for the development of artificial biological systems for research engineering and medical applications. The design and building of new biological parts, equipment, and systems, as well as the re-design of existing, natural biological systems for practical purposes, are all examples of synthetic biology. Furthermore, it has various applications in industrial enzymes, vaccines and antibody production, bio-based chemicals as well as synthetic biological life science research. Synthetic biology is an evolutionary segment of medical technology and market is in the developing stage. Market players and researchers are actively participating in R&D activities to develop and introduce the revolutionary technologies. Furthermore, government funding and support for the research fuelling the market growth. Pharmaceutical and biotechnology businesses spend a lot of money on research in order to produce breakthrough compounds that will meet the rising needs of the healthcare industry and fight new ailments. Collaboration and acquisitions are key strategies adopted by the market players to boost their market revenue share in synthetic biology market. For instance, in March 2015, Synpromics Limited, collaborated with iniQure N.V. to develop synthetic promoters with a specific application in the delivery of gene medicines to the liver. In January 2017, Ginkgo Bioworks, a microorganism company acquired a provider of synthetic DNA Gen9. By this acquisition, company seeks to improve its speed and capacity in constructing new organism design for use across the multiple industries
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Synthetic biology market is driven by the rapid increase in R&D investments in synthetic biology and adaptation of genetically engineered products and DNA sequencing for the treatment and understanding of the diseases progress. In addition, increase in funding from government in life science research and development and advancements in molecular biology expected to boost the synthetic biology during the forecast period. Furthermore, private institutional contribution to synthetic biology research expected to push the market growth. However, lack of regulatory framework, biosafety and biosecurity issues coupled with government policies may hinder the synthetic biology market growth over the forecast period.
Geographically, synthetic biology market has been segmented into Latin America, Europe, Asia- Pacific, North America, and the Middle East & Africa. North America and Europe expected to be a major markets for the synthetic biology owing to the factors such as increase in government funding for the synthetic biology research. According to Woodrow Wilson Center Report, synthetic biology research received about fund of $ 430 Mn in U.S. During 2005 to 2010 European governments contributed $160Mn fund for synthetic biologists. In addition, well-developed healthcare infrastructure and presence of major market players in both regions are expected to drive the market revenue growth. Asia Pacific region expected to grow at notable rate owing to the developing healthcare infrastructure, emergence of the Asia based biotechnological and synthetic biology firms and growing R&D investments in this region.
Latin America
Europe
Asia Pacific
Middle East
North America
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1. Executive Summary |
| 2. Global Synthetic Biology Market Introduction |
| 2.1. Global Synthetic Biology Market – Taxonomy |
| 2.2. Global Synthetic Biology Market –Definitions |
| 2.2.1. Product Type |
| 2.2.2. Technology |
| 2.2.3. Application |
| 2.2.4. Region |
| 3. Global Synthetic Biology Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Current Trends |
| 3.5. Global Synthetic Biology Market Dynamic Factors - Impact Analysis |
| 3.6. Mergers, Acquisitions, and Collaborations |
| 4. Global Synthetic Biology Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 |
| 4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Synthetic Biology Market, By Product Type, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.1. Core Products |
| 5.1.1. Synthetic DNA |
| 5.1.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.1.3. Market Opportunity Analysis |
| 5.1.2. Synthetic Genes |
| 5.1.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.2.3. Market Opportunity Analysis |
| 5.1.3. Synthetic Cells |
| 5.1.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3.3. Market Opportunity Analysis |
| 5.1.4. Chassis organisms |
| 5.1.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.4.3. Market Opportunity Analysis |
| 5.1.5. XNO (Xeno Nucleic Acid) |
| 5.1.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.5.3. Market Opportunity Analysis |
| 5.2. Core Products |
| 5.2.1. DNA Synthesis |
| 5.2.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.1.3. Market Opportunity Analysis |
| 5.2.2. Oligonucleotide Synthesis |
| 5.2.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.2.3. Market Opportunity Analysis |
| 6. Global Synthetic Biology Market, By Technology, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.1. Bioinformatics |
| 6.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Microfluidics |
| 6.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Genetic Engineering |
| 6.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. DNA Sequencing |
| 6.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Nucleotide Synthesis and Sequencing |
| 6.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Integrated Systems |
| 6.6.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7. Global Synthetic Biology Market, By Application, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.1. Pharmaceuticals & Diagnostics |
| 7.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Chemicals |
| 7.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Biofuels |
| 7.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Bioplastics |
| 7.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Global Synthetic Biology Market Forecast, By Region, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific |
| 8.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. MEA |
| 8.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global Synthetic Biology Market - Opportunity Analysis Index, By Product Type, Technology, Application, and Country, 2022 - 2028 |
| 9. North America Synthetic Biology Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 9.1. Product Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Core Products |
| 9.1.1.1. Synthetic DNA |
| 9.1.1.2. Synthetic Genes |
| 9.1.1.3. Synthetic Cells |
| 9.1.1.4. Chassis organisms |
| 9.1.1.5. XNO (Xeno Nucleic Acid) |
| 9.1.2. Enabling Products |
| 9.1.2.1. DNA Synthesis |
| 9.1.2.2. Oligonucleotide Synthesis |
| 9.2. Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1. Bioinformatics |
| 9.2.2. Microfluidics |
| 9.2.3. Genetic Engineering |
| 9.2.4. DNA Sequencing |
| 9.2.5. Nucleotide Synthesis and Sequencing |
| 9.2.6. Integrated Systems |
| 9.3. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1. Pharmaceuticals & Diagnostics |
| 9.3.2. Chemicals |
| 9.3.3. Biofuels |
| 9.3.4. Bioplastics |
| 9.3.5. Others |
| 9.4. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1. United States |
| 9.4.2. Canada |
| 9.5. North America Synthetic Biology Market - Opportunity Analysis Index, By Product Type, Technology, Application, 2016-2027 |
| 9.6. North America Synthetic Biology Market Dynamics – Trends |
| 10. Europe Synthetic Biology Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 10.1. Product Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Core Products |
| 10.1.1.1. Synthetic DNA |
| 10.1.1.2. Synthetic Genes |
| 10.1.1.3. Synthetic Cells |
| 10.1.1.4. Chassis organisms |
| 10.1.1.5. XNO (Xeno Nucleic Acid) |
| 10.1.2. Enabling Products |
| 10.1.2.1. DNA Synthesis |
| 10.1.2.2. Oligonucleotide Synthesis |
| 10.2. Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Bioinformatics |
| 10.2.2. Microfluidics |
| 10.2.3. Genetic Engineering |
| 10.2.4. DNA Sequencing |
| 10.2.5. Nucleotide Synthesis and Sequencing |
| 10.2.6. Integrated Systems |
| 10.3. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1. Pharmaceuticals & Diagnostics |
| 10.3.2. Chemicals |
| 10.3.3. Biofuels |
| 10.3.4. Bioplastics |
| 10.3.5. Others |
| 10.4. Country Level Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1. UK |
| 10.4.2. Germany |
| 10.4.3. France |
| 10.4.4. Italy |
| 10.4.5. Spain |
| 10.4.6. Rest of Europe |
| 10.5. Europe Synthetic Biology Market - Opportunity Analysis Index, By Product Type, Technology, Application, 2016-2027 |
| 10.6. Europe Synthetic Biology Market Dynamics – Trends |
| 11. Asia Pacific Synthetic Biology Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 11.1. Product Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Core Products |
| 11.1.1.1. Synthetic DNA |
| 11.1.1.2. Synthetic Genes |
| 11.1.1.3. Synthetic Cells |
| 11.1.1.4. Chassis organisms |
| 11.1.1.5. XNO (Xeno Nucleic Acid) |
| 11.1.2. Enabling Products |
| 11.1.2.1. DNA Synthesis |
| 11.1.2.2. Oligonucleotide Synthesis |
| 11.2. Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Bioinformatics |
| 11.2.2. Microfluidics |
| 11.2.3. Genetic Engineering |
| 11.2.4. DNA Sequencing |
| 11.2.5. Nucleotide Synthesis and Sequencing |
| 11.2.6. Integrated Systems |
| 11.3. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1. Pharmaceuticals & Diagnostics |
| 11.3.2. Chemicals |
| 11.3.3. Biofuels |
| 11.3.4. Bioplastics |
| 11.3.5. Others |
| 11.4. Country Level Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1. China |
| 11.4.2. India |
| 11.4.3. ANZ |
| 11.4.4. Japan |
| 11.4.5. Rest of APAC |
| 11.5. Asia Pacific Synthetic Biology Market - Opportunity Analysis Index, By Product Type, Technology, Application, 2016-2027 |
| 11.6. Asia Pacific Synthetic Biology Market Dynamics – Trends |
| 12. MEA Synthetic Biology Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 12.1. Product Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Core Products |
| 12.1.1.1. Synthetic DNA |
| 12.1.1.2. Synthetic Genes |
| 12.1.1.3. Synthetic Cells |
| 12.1.1.4. Chassis organisms |
| 12.1.1.5. XNO (Xeno Nucleic Acid) |
| 12.1.2. Enabling Products |
| 12.1.2.1. DNA Synthesis |
| 12.1.2.2. Oligonucleotide Synthesis |
| 12.2. Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Bioinformatics |
| 12.2.2. Microfluidics |
| 12.2.3. Genetic Engineering |
| 12.2.4. DNA Sequencing |
| 12.2.5. Nucleotide Synthesis and Sequencing |
| 12.2.6. Integrated Systems |
| 12.3. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1. Pharmaceuticals & Diagnostics |
| 12.3.2. Chemicals |
| 12.3.3. Biofuels |
| 12.3.4. Bioplastics |
| 12.3.5. Others |
| 12.4. Country Level Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1. GCC Countries |
| 12.4.2. South Africa |
| 12.4.3. Rest of MEA |
| 12.5. MEA Synthetic Biology Market - Opportunity Analysis Index, By Product Type, Technology, Application, 2016-2027 |
| 12.6. MEA Synthetic Biology Market Dynamics – Trends |
| 13. Latin America Synthetic Biology Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 13.1. Product Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Core Products |
| 13.1.1.1. Synthetic DNA |
| 13.1.1.2. Synthetic Genes |
| 13.1.1.3. Synthetic Cells |
| 13.1.1.4. Chassis organisms |
| 13.1.1.5. XNO (Xeno Nucleic Acid) |
| 13.1.2. Enabling Products |
| 13.1.2.1. DNA Synthesis |
| 13.1.2.2. Oligonucleotide Synthesis |
| 13.2. Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Bioinformatics |
| 13.2.2. Microfluidics |
| 13.2.3. Genetic Engineering |
| 13.2.4. DNA Sequencing |
| 13.2.5. Nucleotide Synthesis and Sequencing |
| 13.2.6. Integrated Systems |
| 13.3. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1. Pharmaceuticals & Diagnostics |
| 13.3.2. Chemicals |
| 13.3.3. Biofuels |
| 13.3.4. Bioplastics |
| 13.3.5. Others |
| 13.4. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1. Brazil |
| 13.4.2. Mexico |
| 13.4.3. Argentina |
| 13.4.4. Rest of LA |
| 13.5. Latin America Synthetic Biology Market - Opportunity Analysis Index, By Product Type, Technology, Application, 2016-2027 |
| 13.6. Latin America Synthetic Biology Market Dynamics – Trends |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 14.2.1. Thermo Fisher Scientific, Inc. |
| 14.2.2. Genscript |
| 14.2.3. ProteoGenix |
| 14.2.4. OriGene Technologies Inc. |
| 14.2.5. Integrated DNA technologies |
| 14.2.6. Eurofins Scientific, Inc. |
| 14.2.7. Pareto Biotechnologies |
| 14.2.8. Amyris Inc. |
| 14.2.9. TeselaGen |
| 14.2.10. Synthetic Genomics Inc. |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |